Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$716K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 10 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 28 most recent Form 4 transactions.
| Sep 1 | CRNX | Crinetics Pharmaceuticals,… | DTOISS◆ | 12,500 | $40.29 | $503.6K | — | Open the original filing on SEC.gov |
| Sep 1 | CRNX | Crinetics Pharmaceuticals,… | DTOISS◆ | 17,500 | $64.68 | $1.1M | — | Open the original filing on SEC.gov |
| Sep 1 | CRNX | Crinetics Pharmaceuticals,… | DTOISS◆ | 2,092 | $83.09 | $173.8K | — | Open the original filing on SEC.gov |
| Sep 1 | CRNX | Crinetics Pharmaceuticals,… | DTOISS | 5,925 | $85.00 | $503.6K | -100.0% | Open the original filing on SEC.gov |
| Sep 1 | CRNX | Crinetics Pharmaceuticals,… | DTOISS | 22,836 | $85.00 | $1.9M | -79.4% | Open the original filing on SEC.gov |
| Jun 18 | CRNX | Crinetics Pharmaceuticals,… | AGRANT◆ | 9,730 | — | — | — | Open the original filing on SEC.gov |
| Jun 18 | CRNX | Crinetics Pharmaceuticals,… | AGRANT | 5,925 | — | — | +25.9% | Open the original filing on SEC.gov |
| Jun 9 | ATRA | Atara Biotherapeutics,… | AGRANT | 12,000 | — | — | +66.0% | Open the original filing on SEC.gov |
| May 27 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 80,000 | — | — | — | Open the original filing on SEC.gov |
| May 14 | RARE | Ultragenyx Pharmaceutical… | AGRANT◆ | 14,058 | — | — | — | Open the original filing on SEC.gov |
| May 14 | RARE | Ultragenyx Pharmaceutical… | AGRANT | 7,751 | — | — | +29.9% | Open the original filing on SEC.gov |
| Sep 26, 2025 | CRNX | Crinetics Pharmaceuticals,… | MEXER◷◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 26, 2025 | CRNX | Crinetics Pharmaceuticals,… | SSELL◷ | 16,000 | $44.75 | $716K | -41.2% | Open the original filing on SEC.gov |
| Sep 26, 2025 | CRNX | Crinetics Pharmaceuticals,… | MEXER◷ | 10,000 | $1.91 | $19.1K | +34.7% | Open the original filing on SEC.gov |
| Jun 11, 2025 | CRNX | Crinetics Pharmaceuticals,… | AGRANT◆ | 10,350 | — | — | — | Open the original filing on SEC.gov |
| Jun 11, 2025 | CRNX | Crinetics Pharmaceuticals,… | AGRANT | 6,900 | — | — | +31.5% | Open the original filing on SEC.gov |
| Jun 10, 2025 | ATRA | Atara Biotherapeutics,… | AGRANT | 7,828 | — | — | +75.6% | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 80,000 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 28,571 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 27,802 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 85,586 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | DTOISS◆ | 28,571 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | DTOISS◆ | 27,802 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | DTOISS◆ | 85,586 | — | — | — | Open the original filing on SEC.gov |
| May 15, 2025 | RARE | Ultragenyx Pharmaceutical… | AGRANT◆ | 10,787 | — | — | — | Open the original filing on SEC.gov |
| May 15, 2025 | RARE | Ultragenyx Pharmaceutical… | AGRANT | 5,740 | — | — | +28.4% | Open the original filing on SEC.gov |